InsiderTrades.com logo
50-year Wall Street legend: “Sell this tech stock NOW”
From Chaikin Analytics   |   Ad
Something very strange is happening to U.S. stocks following President Trump's victory... And this could spell disaster for some of America's favorite tech companies.
You can watch for it for free, right here.

ZVRA Insider Trading

Insider Ownership Percentage: 2.40%
Insider Buying (Last 12 Months): $144,300.00
Insider Selling (Last 12 Months): $0.00

Zevra Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Zevra Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Zevra Therapeutics Share Price & Price History

Current Price: $9.59
Price Change: ▲ Price Increase of +0.46 (5.04%)
As of 11/22/2024 01:00 AM ET

This chart shows the closing price history over time for ZVRA up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Buffett Dumps $982 Million in BofA Stock—What Does He Know?
From Genesis Gold Group   |   Ad
Buffett's been eerily quiet about his reasons, but his actions speak volumes. When someone with his track record starts pulling out of the market, it's time to pay attention.
Get your FREE, no-obligation Wealth Protection Guide now

Zevra Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
10/11/2024Corey Michael WattonDirectorBuy500$7.92$3,960.001,500View SEC Filing Icon  
7/17/2024R. Laduane CliftonCFOBuy2,000$6.77$13,540.0018,469View SEC Filing Icon  
7/16/2024Thomas AndersonDirectorBuy10,000$6.81$68,100.0020,000View SEC Filing Icon  
7/12/2024John B BodeDirectorBuy10,000$5.87$58,700.0030,000View SEC Filing Icon  
9/6/2023R. Laduane CliftonCFOBuy1,000$4.96$4,960.0015,309View SEC Filing Icon  
9/5/2023John B BodeDirectorBuy10,000$5.13$51,300.0020,000View SEC Filing Icon  
9/5/2023Joshua SchaferEVPBuy500$5.13$2,565.003,500View SEC Filing Icon  
6/23/2023Corey Michael WattonDirectorBuy275$5.95$1,636.251,000View SEC Filing Icon  
6/9/2023Corey Michael WattonDirectorBuy325$5.52$1,794.00725View SEC Filing Icon  
5/30/2023Corey Michael WattonDirectorBuy400$5.11$2,044.00400View SEC Filing Icon  
5/19/2023Joshua SchaferEVPBuy1,000$5.42$5,420.003,000View SEC Filing Icon  
5/18/2023John B BodeDirectorBuy10,000$5.04$50,400.0010,000View SEC Filing Icon  
5/18/2023R. Laduane CliftonCFOBuy2,740$4.95$13,563.0013,742View SEC Filing Icon  
3/17/2023Tamara A SeymourDirectorBuy519$4.82$2,501.58719View SEC Filing Icon  
3/14/2023Joshua SchaferEVPBuy2,000$4.61$9,220.002,000View SEC Filing Icon  
3/10/2023R. Laduane CliftonCFOBuy1,725$4.15$7,158.7511,002View SEC Filing Icon  
3/10/2023Timothy J SangiovanniSVPBuy1,200$4.14$4,968.004,449View SEC Filing Icon  
3/9/2023Matthew R PloosterDirectorBuy11,000$4.20$46,200.0018,500View SEC Filing Icon  
3/9/2023Richard W PascoeCEOBuy10,000$4.20$42,000.0029,973View SEC Filing Icon  
See Full Table
Let’s be blunt
From DTI   |   Ad
Let me be blunt with you for just a second… You may think you know when and why stocks move, but you’re wrong… Most traders have no idea about the biggest secret Wall Street keeps — even though it’s hiding in plain sight. But once you’ve cracked this code… It could be the breakthrough you need to start targeting $100-$150 a day in the stock market (starting with just $1,000)!
Check out the $100 Challenge now

SEC Filings (Institutional Ownership Changes) for Zevra Therapeutics (NASDAQ:ZVRA)

35.03% of Zevra Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at ZVRA by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Zevra Therapeutics Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/20/2024Virtu Financial LLC18,367$0.13M0.0%N/A0.034%Search for SEC Filing on Google Icon
11/19/2024Barclays PLC57,599$0.40M0.0%+292.6%0.108%Search for SEC Filing on Google Icon
11/16/2024Geode Capital Management LLC1,043,864$7.25M0.0%+14.2%1.984%Search for SEC Filing on Google Icon
11/15/2024Barclays PLC57,599$0.40M0.0%+292.6%0.109%Search for SEC Filing on Google Icon
11/15/2024XTX Topco Ltd13,551$94K0.0%N/A0.026%Search for SEC Filing on Google Icon
11/15/2024State Street Corp772,825$5.36M0.0%+7.4%1.469%Search for SEC Filing on Google Icon
11/14/2024Vestal Point Capital LP525,000$3.64M0.3%N/A0.998%Search for SEC Filing on Google Icon
11/14/2024Stonepine Capital Management LLC700,000$4.86M3.1%N/A1.330%Search for SEC Filing on Google Icon
11/14/2024MetLife Investment Management LLC22,866$0.16M0.0%+8.1%0.043%Search for SEC Filing on Google Icon
11/13/2024Rubric Capital Management LP20,000$0.14M0.0%N/A0.038%Search for SEC Filing on Google Icon
11/13/2024Propel Bio Management LLC179,874$1.25M0.7%N/A0.342%Search for SEC Filing on Google Icon
11/13/2024Quantbot Technologies LP20,243$0.14M0.0%N/A0.038%Search for SEC Filing on Google Icon
11/13/2024FMR LLC2,313,202$16.05M0.0%+282,687.5%4.396%Search for SEC Filing on Google Icon
11/12/2024Valence8 US LP21,596$0.15M0.1%N/A0.041%Search for SEC Filing on Google Icon
11/12/2024Charles Schwab Investment Management Inc.121,356$0.84M0.0%+10.0%0.231%Search for SEC Filing on Google Icon
11/9/2024Intech Investment Management LLC13,748$95K0.0%N/A0.026%Search for SEC Filing on Google Icon
11/6/2024Simplify Asset Management Inc.120,000$0.83M0.0%N/A0.228%Search for SEC Filing on Google Icon
10/29/2024Janney Montgomery Scott LLC305,069$2.12M0.0%-29.5%0.729%Search for SEC Filing on Google Icon
10/24/2024Hunter Associates Investment Management LLC13,260$92K0.0%N/A0.032%Search for SEC Filing on Google Icon
10/22/2024International Assets Investment Management LLC6,940$48K0.0%+594.0%0.017%Search for SEC Filing on Google Icon
10/18/2024IFG Advisors LLC26,400$0.18M0.0%+41.2%0.063%Search for SEC Filing on Google Icon
10/10/2024City State Bank16,224$0.11M0.0%+14.1%0.039%Search for SEC Filing on Google Icon
10/3/2024SG Americas Securities LLC15,198$0.11M0.0%N/A0.036%Search for SEC Filing on Google Icon
9/5/2024Sanctuary Advisors LLC104,924$0.47M0.0%N/A0.199%Search for SEC Filing on Google Icon
8/20/2024Nantahala Capital Management LLC2,419,435$11.86M0.7%-1.4%5.781%Search for SEC Filing on Google Icon
8/15/2024The Manufacturers Life Insurance Company18,573$91K0.0%+15.2%0.044%Search for SEC Filing on Google Icon
8/9/2024Renaissance Technologies LLC112,800$0.55M0.0%-27.4%0.270%Search for SEC Filing on Google Icon
8/9/2024Retirement Planning Co of New England Inc.458,300$2.25M1.2%+6.5%1.095%Search for SEC Filing on Google Icon
8/9/2024Mystic Asset Management Inc.297,947$1.46M0.6%+11.9%0.712%Search for SEC Filing on Google Icon
8/1/2024Rhumbline Advisers56,874$0.28M0.0%+17.9%0.136%Search for SEC Filing on Google Icon
7/26/2024Bank of New York Mellon Corp220,499$1.08M0.0%+10.7%0.527%Search for SEC Filing on Google Icon
5/16/2024Jacobs Levy Equity Management Inc.34,707$0.20M0.0%+102.4%0.083%Search for SEC Filing on Google Icon
5/15/2024Price T Rowe Associates Inc. MD11,011$64K0.0%N/A0.026%Search for SEC Filing on Google Icon
5/10/2024Vanguard Group Inc.1,704,006$9.88M0.0%+3.6%3.924%Search for SEC Filing on Google Icon
5/7/2024Retirement Planning Co of New England Inc.430,193$2.50M1.4%+11.0%0.991%Search for SEC Filing on Google Icon
5/7/2024Mystic Asset Management Inc.266,297$1.55M0.6%+15.4%0.613%Search for SEC Filing on Google Icon
5/7/2024SG Americas Securities LLC12,680$74K0.0%-39.6%0.029%Search for SEC Filing on Google Icon
5/1/2024Janney Montgomery Scott LLC660,169$3.83M0.0%-3.4%1.520%Search for SEC Filing on Google Icon
4/25/2024IFG Advisors LLC18,700$0.11M0.0%+45.0%0.043%Search for SEC Filing on Google Icon
2/26/2024Virtu Financial LLC26,966$0.18M0.0%N/A0.074%Search for SEC Filing on Google Icon
2/13/2024Tower Research Capital LLC TRC9,673$63K0.0%+134.3%0.027%Search for SEC Filing on Google Icon
2/13/2024Armistice Capital LLC268,000$1.76M0.0%N/A0.740%Search for SEC Filing on Google Icon
2/12/2024Focus Financial Network Inc. ADV21,500$0.14M0.0%N/A0.059%Search for SEC Filing on Google Icon
2/8/2024Janney Montgomery Scott LLC683,431$4.48M0.0%+1.3%1.887%Search for SEC Filing on Google Icon
2/7/2024Jump Financial LLC33,200$0.22M0.0%N/A0.092%Search for SEC Filing on Google Icon
2/2/2024Kovack Advisors Inc.141,401$0.93M0.1%+13.9%0.390%Search for SEC Filing on Google Icon
1/30/2024Strs Ohio19,400$0.13M0.0%+151.9%0.054%Search for SEC Filing on Google Icon
1/24/2024International Assets Investment Management LLC6,550$43K0.0%+555.0%0.018%Search for SEC Filing on Google Icon
1/12/2024SG Americas Securities LLC20,999$0.14M0.0%+41.7%0.058%Search for SEC Filing on Google Icon
12/6/2023VisionPoint Advisory Group LLC6,860$33K0.0%N/A0.019%Search for SEC Filing on Google Icon
11/15/2023Laurion Capital Management LP31,200$0.15M0.0%N/A0.086%Search for SEC Filing on Google Icon
11/13/2023Retirement Planning Co of New England Inc.347,402$1.67M0.9%N/A0.959%Search for SEC Filing on Google Icon
11/13/2023Mystic Asset Management Inc.203,283$0.98M0.6%N/A0.561%Search for SEC Filing on Google Icon
11/8/2023Janney Montgomery Scott LLC674,369$3.25M0.0%N/A1.988%Search for SEC Filing on Google Icon
11/7/2023Kingsview Wealth Management LLC12,120$58K0.0%N/A0.036%Search for SEC Filing on Google Icon
10/31/2023IFG Advisors LLC12,900$62K0.0%N/A0.038%Search for SEC Filing on Google Icon
10/26/2023Mirae Asset Global Investments Co. Ltd.19,072$92K0.0%N/A0.056%Search for SEC Filing on Google Icon
10/26/2023Strs Ohio7,700$37K0.0%N/A0.023%Search for SEC Filing on Google Icon
10/24/2023Bank of New York Mellon Corp202,773$0.98M0.0%N/A0.598%Search for SEC Filing on Google Icon
10/24/2023Stratos Wealth Partners LTD.70,200$0.34M0.0%N/A0.207%Search for SEC Filing on Google Icon
10/24/2023Raymond James Financial Services Advisors Inc.26,228$0.13M0.0%N/A0.077%Search for SEC Filing on Google Icon
10/23/2023Commonwealth Equity Services LLC10,858$52K0.0%N/A0.032%Search for SEC Filing on Google Icon
10/18/2023Measured Wealth Private Client Group LLC10,000$48K0.0%N/A0.029%Search for SEC Filing on Google Icon
10/16/2023City State Bank14,224$69K0.0%N/A0.042%Search for SEC Filing on Google Icon
10/13/2023SG Americas Securities LLC14,824$71K0.0%N/A0.044%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Zevra Therapeutics logo
Zevra Therapeutics, Inc. discovers and develops various proprietary prodrugs to treat serious medical conditions in the United States. The company develops its products through Ligand Activated Therapy platform. Its lead product candidate is KP1077, consisting of KP1077IH, which is under Phase 2 clinical trial for the treatment of idiopathic hypersomnia, and KP1077N, which is under Phase ½ clinical trial to treat narcolepsy. The company is also developing Celiprolol, a prodrug product candidate that is under Phase 1/2 clinical trial for the treatment of vascular Ehlers Danlos syndrome. In addition, it offers AZSTARYS, a once-daily treatment for attention deficit hyperactivity disorder in patients aged six years and older; OLPRUVA to treat urea cycle disorders; and Arimoclomol for the treatment of niemann pick disease type C, an ultra-rare neurodegenerative lysosomal storage disorder. The company has collaboration and license agreement with Commave Therapeutics SA to develop, manufacture and commercialize the company's product candidates containing SDX and d-methylphenidate; and license agreement with Acer and Relief Therapeutics, Inc. to develop and commercialize rights for OLPRUVA. The company was formerly known as KemPharm, Inc. and changed its name to Zevra Therapeutics, Inc. in February 2023. Zevra Therapeutics, Inc. was incorporated in 2006 and is headquartered in Celebration, Florida.
Read More on Zevra Therapeutics

Today's Range

Now: $9.59
Low: $9.15
High: $9.64

50 Day Range

MA: $8.16
Low: $6.85
High: $9.13

52 Week Range

Now: $9.59
Low: $4.20
High: $9.64

Volume

677,790 shs

Average Volume

692,713 shs

Market Capitalization

$511.65 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.93

Who are the company insiders with the largest holdings of Zevra Therapeutics?

Zevra Therapeutics' top insider investors include:
  1. John B Bode (Director)
  2. Richard W Pascoe (CEO)
  3. Thomas Anderson (Director)
  4. Matthew R Plooster (Director)
  5. R Laduane Clifton (CFO)
  6. Timothy J Sangiovanni (SVP)
  7. Joshua Schafer (EVP)
  8. Corey Michael Watton (Director)
  9. Tamara A Seymour (Director)
Learn More about top insider investors at Zevra Therapeutics.

Who are the major institutional investors of Zevra Therapeutics?

Zevra Therapeutics' top institutional shareholders include:
  1. FMR LLC — 4.40%
  2. Geode Capital Management LLC — 1.98%
  3. State Street Corp — 1.47%
  4. Stonepine Capital Management LLC — 1.33%
  5. Vestal Point Capital LP — 1.00%
  6. Janney Montgomery Scott LLC — 0.73%
Learn More about top institutional investors of Zevra Therapeutics stock.

Which institutional investors are selling Zevra Therapeutics stock?

Within the previous quarter, ZVRA stock was sold by these institutional investors:
  1. Janney Montgomery Scott LLC

Which institutional investors are buying Zevra Therapeutics stock?

Within the previous quarter, ZVRA stock was acquired by institutional investors including:
  1. FMR LLC
  2. Stonepine Capital Management LLC
  3. Vestal Point Capital LP
  4. Propel Bio Management LLC
  5. Geode Capital Management LLC
  6. Simplify Asset Management Inc.
  7. State Street Corp
  8. Barclays PLC
During the previous year, these company insiders have bought Zevra Therapeutics stock:
  1. John B Bode (Director)
  2. Richard W Pascoe (CEO)
  3. Thomas Anderson (Director)
  4. Matthew R Plooster (Director)
  5. R Laduane Clifton (CFO)
  6. Timothy J Sangiovanni (SVP)
  7. Joshua Schafer (EVP)
  8. Corey Michael Watton (Director)
  9. Tamara A Seymour (Director)
Learn More investors buying Zevra Therapeutics stock.
50-year Wall Street legend: “Sell this tech stock NOW”
From Chaikin Analytics   |   Ad
Something very strange is happening to U.S. stocks following President Trump's victory... And this could spell disaster for some of America's favorite tech companies.
You can watch for it for free, right here.